Ning Han Selected Research

IMM-H004

10/2017	IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
1/2017	Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.
3/2015	Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ning Han Research Topics

Disease

29	Neoplasms (Cancer) 12/2022 - 01/2013
8	Brain Ischemia (Cerebral Ischemia) 01/2022 - 11/2011
6	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2022 - 07/2015
5	Lung Neoplasms (Lung Cancer) 04/2022 - 11/2021
5	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2012
5	Osteonecrosis (Kienbock's Disease) 01/2022 - 05/2010
5	Infections 01/2021 - 04/2008
5	HIV Infections (HIV Infection) 02/2017 - 04/2008
4	Diabetic Nephropathies (Diabetic Nephropathy) 08/2022 - 01/2019
4	Breast Neoplasms (Breast Cancer) 04/2022 - 05/2014
4	Hypertriglyceridemia 01/2022 - 08/2013
4	Inflammation (Inflammations) 01/2022 - 02/2011
4	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
4	Parkinson Disease (Parkinson's Disease) 01/2015 - 03/2011
3	Fatty Liver 01/2020 - 08/2013
3	Ischemia 01/2017 - 03/2015
2	Bites and Stings (Sting) 04/2022 - 01/2022
2	Hypercholesterolemia 01/2022 - 03/2015
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2017
2	Carcinogenesis 01/2022 - 11/2019
2	Brain Injuries (Brain Injury) 01/2022 - 02/2012
2	Pneumonia (Pneumonitis) 11/2021 - 05/2014
2	Pain (Aches) 07/2021 - 10/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2019
2	Body Weight (Weight, Body) 01/2021 - 07/2010
2	Hypoxia (Hypoxemia) 01/2020 - 02/2012
2	Liver Failure 01/2020 - 03/2015
2	Uveal melanoma 12/2019 - 11/2019
2	Renal Insufficiency (Renal Failure) 02/2019 - 03/2015
2	Retinoblastoma (Glioblastoma, Retinal) 01/2019 - 12/2018
2	Osteosarcoma (Osteogenic Sarcoma) 11/2018 - 01/2013
2	Stroke (Strokes) 01/2017 - 06/2014
2	Wounds and Injuries (Trauma) 09/2015 - 03/2015
2	Acquired Immunodeficiency Syndrome (AIDS) 07/2015 - 03/2015
2	Reperfusion Injury 06/2015 - 10/2005
2	Gallstones (Gallstone) 03/2015 - 07/2013
2	Pneumothorax 03/2015 - 10/2014
2	Infarction (Infarctions) 10/2014 - 06/2014
2	Hemorrhage 10/2014 - 06/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2014 - 01/2013
1	Infertility (Sterility) 11/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 08/2022 - 03/2005
8	Pharmaceutical PreparationsIBA 12/2022 - 02/2012
7	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 10/2014
6	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2014
6	Long Noncoding RNAIBA 05/2021 - 11/2018
6	Biological ProductsIBA 01/2021 - 07/2013
5	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2017
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2022 - 11/2021
5	Peptides (Polypeptides)IBA 01/2021 - 02/2012
5	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2009
4	Retinaldehyde (Retinal)IBA 08/2022 - 01/2020
4	phytochlorinIBA 04/2022 - 11/2021
4	AntioxidantsIBA 01/2022 - 03/2015
4	SteroidsIBA 01/2022 - 05/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2017 - 01/2015
4	SynucleinsIBA 01/2015 - 03/2011
4	ChemokinesIBA 10/2014 - 11/2011
3	EnzymesIBA 01/2022 - 01/2016
3	NF-kappa B (NF-kB)IBA 01/2022 - 10/2005
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2020
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 08/2017
3	NucleosidesIBA 01/2022 - 08/2013
3	CytokinesIBA 01/2021 - 02/2011
3	VaccinesIBA 01/2021 - 01/2020
3	IMM-H004IBA 10/2017 - 03/2015
3	Therapeutic UsesIBA 04/2016 - 04/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 07/2010
2	Estrogen ReceptorsIBA 04/2022 - 05/2014
2	Reverse Transcriptase InhibitorsIBA 01/2022 - 08/2013
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 08/2013
2	InterferonsIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2013
2	Ethanol (Ethyl Alcohol)IBA 09/2021 - 01/2020
2	AntigensIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
2	Galactose (Galactopyranose)FDA LinkGeneric 12/2019 - 01/2016
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2018 - 01/2013
2	CoumarinsIBA 10/2017 - 03/2015
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2017 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 05/2014
2	coumarinIBA 01/2017 - 03/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2016 - 09/2010
2	Sevoflurane (Ultane)FDA LinkGeneric 06/2015 - 10/2014
2	CholesterolIBA 03/2015 - 07/2013
2	C19 peptideIBA 10/2014 - 06/2014
2	Propofol (Diprivan)FDA LinkGeneric 10/2014 - 05/2009
2	CC ChemokinesIBA 06/2014 - 02/2012
2	clausenamideIBA 08/2012 - 05/2012
1	dicyclohexyl 2,3-epoxysuccinate (Ep-1)IBA 11/2022
1	Protein Tyrosine PhosphatasesIBA 08/2022

Therapy/Procedure

21	Therapeutics 06/2022 - 04/2006
8	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 10/2006
8	Radiotherapy 01/2022 - 01/2013
6	Drug Therapy (Chemotherapy) 01/2022 - 06/2012
4	Immunotherapy 11/2021 - 01/2020
3	Photochemotherapy (Photodynamic Therapy) 04/2022 - 11/2021
3	Art Therapy 01/2022 - 02/2017
3	Lasers (Laser) 09/2021 - 01/2021
2	Photothermal Therapy 09/2021 - 01/2021